Cargando…

Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis

Recent findings highlight the emerging role of the endocannabinoid system in the control of symptoms and disease progression in multiple sclerosis (MS). MS is a chronic, immune-mediated, demyelinating disorder of the central nervous system with no cure so far. It is widely reported in the literature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gado, Francesca, Digiacomo, Maria, Macchia, Marco, Bertini, Simone, Manera, Clementina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164967/ https://www.ncbi.nlm.nih.gov/pubmed/30111755 http://dx.doi.org/10.3390/medicines5030091

Ejemplares similares

The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders
por: Saponaro, Federica, et al.
Publicado: (2021)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

Application of An Improved HPLC-FL Method to Screen Serine Palmitoyl Transferase Inhibitors
por: Bertini, Simone, et al.
Publicado: (2017)

Enhanced Nutraceutical Properties of Extra Virgin Olive Oil Extract by Olive Leaf Enrichment
por: Cuffaro, Doretta, et al.
Publicado: (2023)

New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
por: Ferrisi, Rebecca, et al.
Publicado: (2023)

Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma
por: Tampucci, Silvia, et al.
Publicado: (2019)

miRNA Modulation and Antitumor Activity by the Extra-Virgin Olive Oil Polyphenol Oleacein in Human Melanoma Cells
por: Carpi, Sara, et al.
Publicado: (2020)

Content Variations in Oleocanthalic Acid and Other Phenolic Compounds in Extra-Virgin Olive Oil during Storage
por: Esposito Salsano, Jasmine, et al.
Publicado: (2022)

Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2013)

CB2-Selective Cannabinoid Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides
por: Lucchesi, Valentina, et al.
Publicado: (2014)

Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
por: Capozzi, Antonella, et al.
Publicado: (2021)

Cannabinoids in the management of spasticity associated with multiple sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2008)

Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
por: Gado, Francesca, et al.
Publicado: (2022)

Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB(2)R)
por: Ferrisi, Rebecca, et al.
Publicado: (2022)

New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
por: Smith, Paul F
Publicado: (2010)

Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells
por: Capozzi, Antonella, et al.
Publicado: (2018)

Olive Mill Wastewater as Source of Polyphenols with Nutraceutical Properties
por: Cuffaro, Doretta, et al.
Publicado: (2023)

A Proteomic Approach to Uncover Neuroprotective Mechanisms of Oleocanthal against Oxidative Stress
por: Giusti, Laura, et al.
Publicado: (2018)

Insights into the Antioxidant/Antiradical Effects and In Vitro Intestinal Permeation of Oleocanthal and Its Metabolites Tyrosol and Oleocanthalic Acid
por: Cuffaro, Doretta, et al.
Publicado: (2023)

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
por: Patti, F, et al.
Publicado: (2016)

Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
por: Giuseppina, Talarico, et al.
Publicado: (2019)

Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns
por: Nouh, Roua A., et al.
Publicado: (2023)

The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver
por: Gabbia, Daniela, et al.
Publicado: (2021)

The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation
por: Carpi, Sara, et al.
Publicado: (2019)

Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment
por: Visser, Leo H, et al.
Publicado: (2016)

Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold
por: Ceni, Costanza, et al.
Publicado: (2022)

Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis
por: Rossi, Silvia, et al.
Publicado: (2013)

Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension
por: Krzyżewska, Anna, et al.
Publicado: (2021)

A Review of Possible Herbal Treatment in Multiple Sclerosis in Traditional Persian Medicine
por: Ghanavati, Rahil, et al.
Publicado: (2016)

Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
por: D’hooghe, Marie, et al.
Publicado: (2021)

Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
por: Giacoppo, Sabrina, et al.
Publicado: (2014)

Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies
por: Vega-García, Angélica, et al.
Publicado: (2021)

Multiple sclerosis - New treatment modalities
por: Totaro, Rocco, et al.
Publicado: (2015)

Vestibular evoked myogenic potential: new perspectives in multiple sclerosis
por: Aidar, Renata Chade, et al.
Publicado: (2015)

The use of traditional and complementary medicine among patients with multiple sclerosis in Belgium
por: Huybregts, E, et al.
Publicado: (2018)

Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis
por: Torres-Moreno, Mari Carmen, et al.
Publicado: (2018)

Correlation of Nabiximols Dose to Steady-State Concentrations of Cannabinoids in Urine Samples from Patients with Multiple Sclerosis
por: Birke, Rüdiger, et al.
Publicado: (2022)

Is non-traditional therapy for multiple sclerosis overwhelming in Saudi Arabia
por: Shariff, Erum M., et al.
Publicado: (2019)

Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report
por: Lou, Kelvin, et al.
Publicado: (2021)

The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis
por: Naderi, Nima
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bpes379f3l9h3p295u1klhq5jq